The FDA has approved a new breast cancer drug that avoids healthy cells while it targets tumors, reported the Associated Press. The drug, Kadcyla, is a combination of a chemotherapy drug, another drug called Herceptin, and a chemical that keeps them combined until the drug cocktail meets the tumor....
![]()
![]()
![]()
![]()
![]()
↧